首页|期刊导航|时珍国医国药|基于肠-肝轴探讨芪茵颗粒防治非酒精性脂肪肝的作用机制

基于肠-肝轴探讨芪茵颗粒防治非酒精性脂肪肝的作用机制OA

Exploring the mechanism of action of Qiyin Granule(芪茵颗粒)against non-alcoholic fatty liver based on the intestinal-hepatic axis

中文摘要英文摘要

目的 探究芪茵颗粒对非酒精性脂肪肝(NAFLD)模型大鼠肝脏与肠道病理损伤的改善作用及相关机制,明确其剂量效应.方法 将大鼠分为空白组(C组)、模型组(HF组)、芪茵颗粒低(L组)、中(M组)、高(H组)剂量组及阳性药组(MT组).C组除外的各组大鼠经高脂高糖饲料喂养9周建立NAFLD模型.除空白组和模型组外,其余各组均给予相应药物干预4周.通过HE染色观察各组大鼠肝脏与肠道组织形态;免疫组化检测肠道炎症因子TNF-α和NF-κB;血清检测肠屏障标志物LPS、DAO和D-LA;WB检测紧密连接蛋白ZO-1和Occludin;并结合16SrDNA分析肠道菌群多样性、组成及功能通路.结果 与C组相比HF组肝小叶结构破坏、肝细胞脂滴蓄积,肠道黏膜损伤、绒毛萎缩;伴随TNF-α和NF-κB表达升高(P<0.01);肠屏障标志物LPS、DAO和D-LA升高(P<0.05);紧密连接蛋白ZO-1和Occludin下调(P<0.05);且肠道菌群多样性紊乱Shannon升高和Chao1骤降,核心菌门Firmicutes降低和Proteobacteria升高及属水平产短链脂肪酸菌减少异常,菌群代谢通路受损.与HF组相比,M组上述指标改善最显著:肝肠组织形态接近正常,炎症因子与肠屏障标志物水平回调,ZO-1/Occludin 表达上调(P<0.05),菌群多样性、组成及功能通路趋近正常,效果优于L组和H组.结论 芪茵颗粒可通过修复肠屏障、抑制肠道炎症、调控肠道菌群结构与功能改善NAFLD,其中中剂量效果最优,为NAFLD的临床干预提供实验依据.

Objective To investigate the ameliorative effect of Qiyin Granule(芪茵颗粒,QYG)on liver and intestinal pathologic injury in rats modeled for non-alcoholic fatty liver disease(NAFLD)and related mechanisms,and to clarify the dose effect.Methods The rats were divided into the control group(Group C),the model group(Group HF),the low(Group L),medium(Group M)and high(Group H)dose groups of QYG and the positive drug group(Group MT).After the rats in each group were fed with high-fat and high-sugar feed for 9 weeks to establish the NAFLD model,all groups except the blank group and the model group were given the corresponding drug interventions for 4 weeks,and the liver and intestinal tissue morphology of each group were observed by HE staining,the intestinal inflammatory factors(TNF-α,NF-κB)were detected by immunohistochemistry,the intestinal barrier markers(LPS,DAO,D-LA)were detected by enzyme kits,and the tight junction proteins(ZO-1,D-LA),ZO-1,and ZO-2 were detected by WB.junction proteins(ZO-1,Occludin),and combined with 16srDNA to analyze the diversity,composition and functional pathways of intestinal flora.Results Compared with group C,the HF group showed structural disruption of liver lobules,accumulation of lipid droplets in hepato-cytes,intestinal mucosal damage,villi atrophy,accompanied by elevated expression of TNF-α/NF-κB(P<0.01),elevated intestinal barrier markers,and down-regulation of tight junction proteins,as well as disturbed diversity of intestinal flora(Shannon elevated,Chao1 plummeted),core phylum(Firmicutes lowered,Proteobacteria elevated)The diversity of the intestinal flora was disturbed(Shannon increased,Chao1 decreased abruptly),the core phylum(Firmicutes decreased,Proteobacteria increased)and the genus level(short-chain fatty acid-producing bacteria decreased)were abnormal,and the metabolic pathway of the flora was damaged.Com-pared with HF group,M group showed the most significant improvement in the above indexes:the morphology of liver and intestinal tis-sues was close to normal,the levels of inflammatory factors and intestinal barrier markers were regulated,the expression of ZO-1/Occlu-din was up-regulated(P<0.05),and the diversity and composition of flora and its functional pathways were close to normal,which was better than that of L group and H group.Conclusion QYG can improve NAFLD by repairing the intestinal barrier,inhibiting intestinal inflammation,and regulating the structure and function of intestinal flora,with the best effect in the middle dose,which can provide an experimental basis for the clinical intervention of NAFLD.

胡锋杰;曹峰铭;姚秋月;王彦顺;周英

新疆医科大学,新疆 乌鲁木齐 830054新疆医科大学,新疆 乌鲁木齐 830054新疆医科大学,新疆 乌鲁木齐 830054新疆医科大学,新疆 乌鲁木齐 830054新疆医科大学,新疆 乌鲁木齐 830054

医药卫生

芪茵颗粒非酒精性脂肪肝肝肠轴肠道菌群

Qiyin Granule(芪茵颗粒)Non-alcoholic fatty liver diseaseLiver-intestinal axisIntestinal flora

《时珍国医国药》 2026 (18)

3456-3465,10

新疆维吾尔自治区自然科学基金(2022D01C450)天池英才引进计划项目

10.70976/j.1008-0805.SZGYGY-2026-1808

评论